Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Jin Medical International (ZJYL) Cash & Current Investments (2022 - 2025)

Historic Cash & Current Investments for Jin Medical International (ZJYL) over the last 4 years, with Q3 2025 value amounting to $30.3 million.

  • Jin Medical International's Cash & Current Investments rose 1860.62% to $30.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $30.3 million, marking a year-over-year increase of 1860.62%. This contributed to the annual value of $30.3 million for FY2025, which is 1860.62% up from last year.
  • Jin Medical International's Cash & Current Investments amounted to $30.3 million in Q3 2025, which was up 1860.62% from $28.0 million recorded in Q1 2025.
  • Over the past 5 years, Jin Medical International's Cash & Current Investments peaked at $30.3 million during Q3 2025, and registered a low of $2.3 million during Q3 2022.
  • In the last 4 years, Jin Medical International's Cash & Current Investments had a median value of $24.0 million in 2024 and averaged $19.2 million.
  • As far as peak fluctuations go, Jin Medical International's Cash & Current Investments skyrocketed by 53973.88% in 2023, and later surged by 1629.71% in 2025.
  • Jin Medical International's Cash & Current Investments (Quarter) stood at $2.3 million in 2022, then surged by 539.74% to $14.6 million in 2023, then soared by 75.47% to $25.6 million in 2024, then increased by 18.61% to $30.3 million in 2025.
  • Its Cash & Current Investments stands at $30.3 million for Q3 2025, versus $28.0 million for Q1 2025 and $25.6 million for Q3 2024.